mutations and complicated kar yotype. It follows a linear evolution from the CLL clone in the recurrent acquisition of CDKN2AOver the past many years, the number of sufferers referred for allogeneic hematopoietic mobile transplantation has dropped significantly,133 nevertheless the treatment need to be suggested to younger/in shape clients in whom